JCRB1599 hTf30-8H
Cell information
Cell type:general cells (View Pricing Information)
JCRB No. | JCRB1599 | Cell Name | hTf30-8H |
---|---|---|---|
Profile | This cell line produce monoclonal antibody against human transferrin. | Other Name | |
Animal | mouse x mouse | Strain | BALB/c |
Genus | hybridoma | Species | |
Sex | Age | ||
Identity | not done | Tissue for Primary Cancer | |
Case history | Metastasis | ||
Tissue Metastasized | Genetics | ||
Life Span | infinite | Crisis PDL | |
Morphology | lymphocyte-like | Character | This cell line produce monoclonal antibody against human transferrin. Antibody's subclass; IgG1, kappa. BALB/c mouse spleen x P3U1 myeloma (BALB/c) |
Classify | hybridoma | Established by | Mebiopharm Co.,Ltd |
Registered by | Mebiopharm Co.,Ltd | Regulation for Distribution | |
Comment | Year | 2011 | |
Medium | RPMI1640 medium with 10% FBS. | Methods for Passages | dilution |
Cell Number on Passage | Race | ||
CO2 Conc. | 5% | Tissue Sampling | |
Tissue Type |
Detection of virus genome fragment by Real-time PCR | |||||||||
---|---|---|---|---|---|---|---|---|---|
Detected DNA Virus | not tested | Detected RNA Virus | not tested |
Images |
---|
LOT Information
Cell No. | JCRB1599 | Cell Name | hTf30-8H |
---|---|---|---|
LOT No. | 07172014 | Lot Specification | distribution |
Medium | RPMI1640 medium(GIBCO) with 10% heat inactivated fetal bovine serum(SIGMA027K03911) | Temperature | 37 C |
Cell Density at Seeding | 8.6-8.8x10^4 cells/ml | Methods for Passages | Dilution |
Doubling Time | NT | Cell Number in Vial (cells/1ml) | 1.2x10^6 |
Viability at cell freezing (%) | 83.6 | Antibiotics Used | free |
Passage Number | p4* | PDL | NT |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | NT |
Chromosome Mode | NT | Chromosome Information | NT |
Surface Antigen | NT | DNA Profile (STR) | |
Adhesion | No | Exoteric Gene | NT |
Medium for Freezing | Cell Banker BLC-1(Nihon Zenyaku Industries) | CO2 Conc. | 5 % |
Viability immediately after thawing (%) | Additional information |
Images |
---|